References
- Catherinot E, Lanternier F, Bougnoux ME, Lecuit M, Couderc LJ, Lortholary O. Pneumocystis jirovecii pneumonia. Infect Dis Clin North Am 2010;24:107–38.
- Pfaller MA, Anaissie EJ. Pneumocystis. In: Anaissie EJ, McGinnis MR, Pfaller MA, editors. Clinical mycology. 2nd ed. Oxford, UK: Churchill Livingstone; 2009 pp 385–401.
- Salomon N, Perlman DC. Cytomegalovirus pneumonia. Semin Respir Infect 1999;14:353–8.
- Benfield TL, Helweg-Larsen J, Bang D, Junge J, Lundgren JD. Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia. Chest 2001;119: 844–51.
- Bozzette SA, Arcia J, Bartok AE, McGlynn LM, McCutchan JA, Richman DD, . Impact of Pneumocystis carinii and cytomegalovirus on the course and outcome of atypical pneumonia in advanced human immunodeficiency virus disease. J Infect Dis 1992;165:93–8.
- Hayner CE, Baughman RP, Linnemann CC Jr, Dohn MN. The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV. Chest 1995;107:735–40.
- Jacobson MA, Mills J, Rush J, Peiperl L, Seru V, Mohanty PK, . Morbidity and mortality of patients with AIDS and first-episode Pneumocystis carinii pneumonia unaffected by concomitant pulmonary cytomegalovirus infection. Am Rev Respir Dis 1991;144:6–9.
- Jensen AM, Lundgren JD, Benfield T, Nielsen TL, Vestbo J. Does cytomegalovirus predict a poor prognosis in Pneumocystis carinii pneumonia treated with corticosteroids? A note for caution. Chest 1995;108:411–4.
- Miles PR, Baughman RP, Linnemann CC Jr. Cytomegalovirus in the bronchoalveolar lavage fluid of patients with AIDS. Chest 1990;97:1072–6.
- Angelici E, Contini C, Sebastiani G, Folgori F, Delia S, Serra P, . Cytomegalovirus in bronchoalveolar lavage specimens from patients with AIDS: comparison with antigenaemia and viraemia. J Med Microbiol 1996;45:149–52.
- Laursen AL, Mogensen SC, Andersen HM, Andersen PL, Ellermann-Eriksen S. The impact of CMV on the respiratory burst of macrophages in response to Pneumocystis carinii. Clin Exp Immunol 2001;123:239–46.
- Qureshi MH, Garvy BA, Pomeroy C, Inayat MS, Oakley OR. A murine model of dual infection with cytomegalovirus and Pneumocystis carinii: effects of virus-induced immunomodulation on disease progression. Virus Res 2005;114:35–44.
- Ewig S, Bauer T, Schneider C, Pickenhain A, Pizzulli L, Loos U, . Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients. Eur Respir J 1995;8:1548–53.
- Mansharamani NG, Garland R, Delaney D, Koziel H. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000;118:704–11.
- Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group. Eur Respir J 1989;2:561–85.
- Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309–32.
- Smego RA Jr, Nagar S, Maloba B, Popara M. A meta-analysis of salvage therapy for Pneumocystis carinii pneumonia. Arch Intern Med 2001;161:1529–33.
- Tamm M, Traenkle P, Grilli B, Soler M, Bolliger CT, Dalquen P, . Pulmonary cytomegalovirus infection in immunocompromised patients. Chest 2001;119:838–43.